These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2477125)

  • 1. Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils.
    Nabe M; Agrawal DK; Sarmiento EU; Townley RG
    Clin Exp Allergy; 1989 Sep; 19(5):515-20. PubMed ID: 2477125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of terfenadine on pulmonary function, histamine release, and bronchial challenges with nebulized water and cold-air hyperventilation.
    Townley RG; Hopp RJ; Bewtra AK; Nabe M
    Ann Allergy; 1989 Nov; 63(5):455-60. PubMed ID: 2479303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjects.
    van der Donk EM; Blok W; Kok PT; Bruijnzeel PL
    Prostaglandins Leukot Essent Fatty Acids; 1991 Sep; 44(1):11-7. PubMed ID: 1719566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
    Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G
    J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin.
    Marone G; Columbo M; Triggiani M; Cirillo R; Genovese A; Formisano S
    Biochem Pharmacol; 1987 Jan; 36(1):13-20. PubMed ID: 2432900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiallergic effects of terfenadine on immediate type hypersensitivity reactions.
    Akagi M; Mio M; Miyoshi K; Tasaka K
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):257-79. PubMed ID: 2449487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct effects of second-generation H1-receptor antagonists on the activation of human basophils.
    Ramachers U; Amon U; Wolff HH
    Agents Actions; 1994 Jun; 41 Spec No():C45-6. PubMed ID: 7526656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cord blood basophil releasability: evaluation of histamine release and leukotriene C4 generation.
    Miadonna A; Leggieri E; Tedeschi A; Lorini M; Motta G; Lucci G; Froldi M; Marini A; Zanussi C
    Int Arch Allergy Appl Immunol; 1988; 86(1):42-7. PubMed ID: 2453473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of the H1 antagonist loratadine on histamine release from human basophils.
    Miadonna A; Milazzo N; Lorini M; Marchesi E; Tedeschi A
    Int Arch Allergy Immunol; 1994 Sep; 105(1):12-7. PubMed ID: 7522069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of human blood basophils and leukotriene C4 generation following calcium ionophore stimulation.
    Mita H; Akiyama K; Hayakawa T; Yamada T; Ikeda Y; Shida T
    Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):783-8. PubMed ID: 7505057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of terfenadine and flurbiprofen on early and late-phase bronchoconstriction following allergen challenge in atopic asthma.
    Hamid M; Rafferty P; Holgate ST
    Clin Exp Allergy; 1990 May; 20(3):261-7. PubMed ID: 1694714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
    Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
    Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
    García G; DeMora F; Ferrer L; Puigdemont A
    Am J Vet Res; 1997 Mar; 58(3):293-7. PubMed ID: 9055977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionic regulation of human basophil releasability. I. Inhibitory effect of copper.
    Tedeschi A; Arquati M; Lorini M; Milazzo N; Miadonna A
    Agents Actions; 1992 Sep; 37(1-2):16-24. PubMed ID: 1280906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
    Naclerio RM; Kagey-Sobotka A; Lichtenstein LM; Freidhoff L; Proud D
    Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc.
    Marone G; Findlay SR; Lichtenstein LM
    J Pharmacol Exp Ther; 1981 May; 217(2):292-8. PubMed ID: 6164779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949.
    Conroy MC; Kennedy JA; Chestnut JC; Wright CD; Adolphson RL; Thueson DO
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 1):902-8. PubMed ID: 1702129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine.
    Kleine-Tebbe J; Josties C; Frank G; Stalleicken D; Buschauer A; Schunack W; Kunkel G; Czarnetzki B
    J Allergy Clin Immunol; 1994 Feb; 93(2):494-500. PubMed ID: 7509820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.